MedTrace Logo

Therapeutic Education of Chronic Renal or Renal Transplant Patient in the Management of EPO Injections

NCT03481686 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2022-06-23

No results posted yet for this study

Summary

In chronic kidney disease, ESAs (Erythropoiesis-stimulating agents) are used to treat anemia. This anemia is due to decreased renal production of erythropoietin (EPO), a hormone that stimulates the production of red blood cells in the bone marrow. Treatment of anemia increases survival, decreases morbidity and improves quality of life and exercise tolerance.

Self-administration of ASE has been encouraged for many years, notably with pens for injection, but only few patients are educated in the injection technique.

The investigators therefore wish to lead a study in the Nephrology department of Rennes University Hospital to educate the patient, or his or her spouse, on ESA injections during hospitalization, in order to empower the patient in his care, and with the second aim of reducing the costs of chronic renal insufficiency.

Conditions

  • Renal Insufficiency, Chronic
  • Organ Graft

Interventions

DEVICE

Patients with injections of ESA

Patients will perform ASE injections themselves or by their spouses

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Cécile VIGNEAU · CHU Rennes

  • Hugoline BOULAY · CHU Rennes

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-21
Primary Completion
2022-02-09
Completion
2022-02-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03481686 on ClinicalTrials.gov